CVE-2026-25112

Exploitation

Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.

SSVC decision

• ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
• AutomatablenoAt least one step from reconnaissance to exploitation cannot be reliably automated.
• Technical ImpacttotalSuccessful exploitation gives total control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

0.14% probability of exploitation activity in the next 30 days.

EPSS percentile

Ranks above 4.3% of scored records. A rank, not a probability.

NVD base score

7.8 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

NVD analysis status

Awaiting Analysis. NVD last modified this record on 2026-07-24.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2026-05-26 14:52Z3 MO AGO

Last updated

2026-06-09 07:13Z2 MO AGO

Reserved

2026-03-04

Assigning CNA

Genetec

Record state

PUBLISHED

Severity

High (CVSS 7.8)

CNA CVSS vector

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Weaknesses

• CWE-732Incorrect Permission Assignment for Critical ResourceClass

Data version

5.2

Document digest

f86d561993496a67c31862084cd4e5844ef636b27afdd008e17f2790496d9b9b

• resources.genetec.comhttps://resources.genetec.com/security-advisories/vulnerability-affecting-rabbitmq-deployment-in-genetec-products
• ressources.genetec.comhttps://ressources.genetec.com/bulletins-de-securite/vulnerabilite-d-elevation-de-privileges-affectant-le-deploiement-de-rabbitmq-dans-les-produits-genetec
• seclists.orghttp://seclists.org/fulldisclosure/2026/Jun/2